Fig. 2From: A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial CarcinomaQuantification of IGFBP7-AS1 and IGFBP7 levels by RT-qPCR. A, B Expression levels of IGFBP7-AS1 and IGFBP7 in UCEC samples and paired adjacent samples. C Significant correlation between IGFBP7-AS1 and IGFBP7 levels in tumor samplesBack to article page